Bioterápico 17DH T. cruzi em uso prolongado melhora clinicamente camundongos infectados pelo Trypanosoma cruzi / Biotherapic T. cruzi 17DH when continuously used clinically improves mice infected with Trypanosoma cruzi.
Aleixo, Denise Lessa ; Ferreira, Érika Cristina ; Braga, Caroline Felício; Lopes, Carina Ribeiro ; Falkowski, Gislaine Janaina Sanchez ; Sandri, Patrícia Flora ; Araújo, Silvana Marques de.
Int. j. high dilution res
; 10(36): 134-137, september 30, 2011.
Article
in English
|
LILACS-Express
| ID: hom-10720
Introduction:
In Trypanosoma cruzi infection, the pathogenesis is the result of a rupture in the host - parasite relationship [1]. This rupture is related to the imbalance of the vital force of the host, expressed through signs and symptoms, defined by Hahnemann (1995)[2] as being the source of the disease. There is no research in the literature about the clinical evolution of mice experimentally infected with T. cruzi and treated in different ways using biotherapic. Therefore, this is an area to be studied in the future.Conclusion:
The use of biotherapic T. cruzi 17DH for a long period causes clinical improvement of the infected mice with Trypanosoma cruzi. The clinical use of these results in human beings should consider the allometric medicine dosage which takes into account the metabolic rate of each organism(AU)
Responsible library:
BR1.1
Fulltext
Related documents
